Jaringan Laboratorium Medis

Vol. 7 No. 2 (2025): November 2025
Original Articles

Fluctuation of SGOT and SGPT Enzyme Activity in Breast Cancer Patient Undergoing Chemotherapy at NTB Provincial Hospital

PDF
  • Fadila Rizki Ananda,
  • Erlin Yustin Tatontos,
  • Fihiruddin Fihiruddin
Fadila Rizki Ananda
Poltekkes Kemenkes Mataram
Erlin Yustin Tatontos
Poltekkes Kemenkes Mataram
Fihiruddin Fihiruddin
Poltekkes Kemenkes Mataram
DOI: https://doi.org/10.31983/jlm.v7i2.13322

Published 2025-11-01

Keywords

  • Chemotherapy,
  • SGOT,
  • SGPT

How to Cite

Ananda, F. R., Tatontos, E. Y., & Fihiruddin, F. (2025). Fluctuation of SGOT and SGPT Enzyme Activity in Breast Cancer Patient Undergoing Chemotherapy at NTB Provincial Hospital. Jaringan Laboratorium Medis, 7(2), 143–152. https://doi.org/10.31983/jlm.v7i2.13322

Copyright (c) 2025 Jaringan Laboratorium Medis

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Abstract

Chemotherapy is one of the primary treatment for breast cancer. Despite its effectiveness, chemotherapy has the potential to cause hepatotoxicity due to drug metabolism in the liver. This condition is generally indicated by elevated levels of SGOT and SGPT enzymes. Liver enzyme monitoring is essential to assess hepatocellular function throughout the course of therapy. This research aims to determine fluctuations in SGOT and SGPT enzyme activity in breast cancer patient undergoing chemotherapy at the NTB Provincial Hospital, and describe the pattern of changes in enzyme values based on the frequency of chemotherapy cycles. An analytical observational study with a cross-sectional approach was employed. Samples were selected purposively based on the medical records of breast cancer patients who underwent 1 to 6 cycles of chemotherapy between January and December 2024. Data were analyzed descriptively based on the distribution and the average of SGOT and SGPT enzyme levels. The results showed fluctuating SGOT and SGPT levels across different chemotherapy cycles. There was no consistent pattern of increase in enzyme activity based on chemotherapy frequency.  The average SGOT levels from cycle 1 to 6 were 24, 28, 27, 30, 33, and 24 IU/L, while the average SGPT levels were 35, 27, 29, 25, 29, and 29 IU/L, with a range of SGOT values of 13-404 IU/L and SGPT with a range of 5-304 IU/L. most enzyme values remained within normal range. It was concluded that chemotherapy frequency did not show a consistent association with increased SGOT and SGPT activity. These research emphasize the importance of routine monitoring of liver function during each chemotherapy cycle, so that potential hepatotoxicity can be adjusted according to the patient condition.

 

PDF

References

  1. Andinata, A., Marni, E., & Erianti, S. (2020). Hubungan Mekanisme Koping Dengan Tingkat Kecemasan Pasien Kanker Yang Menjalani Kemoterapi. Jurnal Cakrawala Promkes, 2(2), 45. https://doi.org/10.12928/promkes.v2i2.1719
  2. Anggraini, S., Izzah, A. Z., Anggraini, F. T., Alioes, Y., Handayani, T., Dokter, P., Kedokteran, F., Ilmu, D., Anak, K., Fisiologi, D., & Biokimia, D. (2024). Fungsi Hati Anak Leukemia Limfoblastik Akut dalam Kemoterapi Fase Induksi berdasarkan Usia dan Status Gizi 1. 26(3), 131–136.
  3. Arafah, A. B. R., & Notobroto, H. B. (2018). Faktor Yang Berhubungan Dengan Perilaku Ibu Rumah Tangga Melakukan Pemeriksaan Payudara Sendiri (Sadari). The Indonesian Journal of Public Health, 12(2), 143. https://doi.org/10.20473/ijph.v12i2.2017.143-153
  4. Baldo, B. A., & Pham, N. H. (2013). Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch. Cancer and Metastasis Reviews, 32(3–4), 723–761. https://doi.org/10.1007/s10555-013-9447-3
  5. Christina, I., Setyawati, A. N., & Tjahjono, K. (2016). Pengaruh Ekstrak Daun Dewa (Gynura divaricata) Terhadap Kadar Ureum dan Kreatinin (Studi Eksperimental Pada Tikus Model Kanker Payudara). Jurnal Kedokteran Diponegoro, 5(4), 1013–1025. http://ejournal-s1.undip.ac.id/index.php/medico
  6. David, S., & Hamilton, J. P. (2023). Drug-induced liver injury. Krankenhauspharmazie, 44(1), 3–9. https://doi.org/10.29309/tpmj/2017.24.11.669
  7. Dewi, S. U., Mahardika Venansius Purba, A., Mahardika, P., Puspita, R., Latipah, S., & Anggraini, Y. (2024). Epidemiologi Kanker (R. Watrianthos (ed.)). Yayasan Kita Menulis.
  8. Fatemi Shandiz, A., Karimi, G., Dayyani, M., Hosseini, S., & Elyasi, S. (2024). Evaluation of oral silymarin formulation efficacy in prevention of doxorubicin induced hepatotoxicity in patients with non-metastatic breast cancer. Journal of Oncology Pharmacy Practice, 10781552241268778. https://doi.org/10.1177/10781552241268778
  9. Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2022). Cancer statistics for the year 2020: An overview. International Journal of Cancer, 149(4), 778–789. https://doi.org/10.1002/ijc.33588
  10. Haryani, S. (2022). Evaluasi Penggunaan Obat Kemoterapi Pada Pasien Kanker Payudara Di RSUP Fatmawati Periode Februari 2021. Jurnal Farmasi Klinik Base Practice, 1(1), 50–60. https://doi.org/10.58815/jfklin.v1i1.19
  11. Islam, T., Rahman, A. K. M. S., Hasan, M. K., Jahan, F., Mondal, M. C., Ferdoushi, S., Alam, S., Ahsan, M. K., Tasnim, J., & Tohura, S. (2020). Liver Function Tests in Patients of Acute Leukemia before and after Induction Chemotherapy. Journal of Biosciences and Medicines, 08(02), 110–121. https://doi.org/10.4236/jbm.2020.82009
  12. Jee, A., Sernoskie, S. C., & Uetrecht, J. (2021). Idiosyncratic drug-induced liver injury: Mechanistic and clinical challenges. International Journal of Molecular Sciences, 22(6), 1–26. https://doi.org/10.3390/ijms22062954
  13. Kementerian Kesehatan RI. (2022). Panduan Pelaksanaan Hari Kanker Sedunia 2022. Kementerian Kesehatan RI, 1–17. https://promkes.kemkes.go.id/download/ftjl/files90159BUKU PANDUAN HKS 2022 (3).pdf
  14. Kurniasih, H. (2021). Buku Saki Deteksi Dini Kanker Payudara.
  15. Leser, C., Dorffner, G., Marhold, M., Rutter, A., Döger, M., Singer, C., König-Castillo, D. M., Deutschmann, C., Holzer, I., König-Castillo, D., & Gschwantler-Kaulich, D. (2023). Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective study. PLoS ONE, 18(3 March), 1–10. https://doi.org/10.1371/journal.pone.0278454
  16. Mudd, T. W., & Guddati, A. K. (2021). Chemotherapy Tox..Pdf. 11(7), 3461–3474.
  17. Purwanto, T., & Sangging, P. R. A. (2023). Etiologi, patofisiologi, evaluasi, dan tatalaksana drug induced hepatotoxicity. Medula, 13(3), 322–326. https://journalofmedula.com/index.php/medula/article/download/636/510
  18. Rosida, A. (2016). Pemeriksaan Laboratorium Penyakit Hati. Berkala Kedokteran, 12(1), 123–131. https://doi.org/10.5005/jp/books/10446_15
  19. RSUD NTB. (2022). Laporan Tahunan Rumah Sakit Umum Daerah Provinsi Nusa Tenggara Barat Tahun.
  20. Ruiz de Porras, V., Figols, M., Font, A., & Pardina, E. (2023). Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury. Life Sciences, 332, 2023–2025. https://doi.org/10.1016/j.lfs.2023.122119
  21. Sa’adah, N., Nurhayati, A., & Shovitri, M. (2017). The Anticancer Activity of the Marine Sponge Aaptos suberitoides to Protein Profile of Fibrosarcoma Mice (Mus musculus). IPTEK The Journal for Technology and Science, 27. https://doi.org/10.12962/j20882033.v27i3.1183
  22. Suryatno, & Pasaribu, E. T. (2014). Bedah Onkologi Diagnosis dan Terapi.
  23. Tang, X., Gao, D., Liu, X., Liu, J., Chen, T., & He, J. (2024). Novel RGD-decorated micelles loaded with doxorubicin for targeted breast cancer chemotherapy. Biomedicine and Pharmacotherapy, 180(July), 117460. https://doi.org/10.1016/j.biopha.2024.117460
  24. Tsani, R. A., Setiani, O., & Dewanti, N. A. Y. (2017). Hubungan Riwayat Pajanan Pestisida Dengan Gangguan Fungsi Hati Pada Petani Di Desa Sumberejo Kecamatan Ngablak Kabupaten Magelang. Jurnal Kesehatan Masyarakat, 5(3), 411–420. http://ejournal-s1.undip.ac.id/index.php/jkm
  25. Verdial, F. C., Mamtani, A., Pawloski, K. R., Sevilimedu, V., D’Alfonso, T. M., Zhang, H., Gemignani, M. L., Barrio, A. V., Morrow, M., & Tadros, A. B. (2022). The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer. Annals of Surgical Oncology, 29(6), 3810–3819. https://doi.org/10.1245/s10434-022-11367-w
  26. Widarti, W., & Nurqaidah, N. (2019). Analisis Kadar Serum Glutamic Pyruvic Transaminase (Sgpt) Dan Serum Glutamic Oxaloacetic Transaminase (Sgot) Pada Petani Yang Menggunakan Pestisida. Jurnal Media Analis Kesehatan, 10(1), 35. https://doi.org/10.32382/mak.v10i1.984
  27. Yang, L., Price, E. T., Chang, C. W., Li, Y., Huang, Y., Guo, L. W., Guo, Y., Kaput, J., Shi, L., & Ning, B. (2013). Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters. PLoS ONE, 8(4), 1–12. https://doi.org/10.1371/journal.pone.0060368
  28. Yuliana, D. (2024). Literature Review : Perkembangan Pengobatan Kemoterapi Kanker Payudara. Makassar Pharmaceutical Science Journal, 2(1), 32–40.
  29. Zangouri, V., Balaneji, S. S., Golmoradi, R., Kafili, E., Bologhi, S., Mousavi, S. A., Hesar, A. A., & Amestejani, M. (2025). Effects of BMI on prognosis, disease-free survival and overall survival of breast cancer. BMC Cancer, 25(1). https://doi.org/10.1186/s12885-025-13638-7